Plain-English translation of NCT03175471 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing whether special MRI scans can detect damage to the bile ducts and liver fibrosis (scarring) in young people with autoimmune liver disease—conditions where the immune system mistakenly attacks liver cells. The study compares what the MRI scans show with blood test results and tissue samples to see if MRI is a reliable, non-invasive way to measure disease damage.
Currently, doctors often need to do liver biopsies (taking a tissue sample) to check for liver damage in patients with autoimmune liver disease. This study exists to find out if advanced MRI scans can detect the same information without needing an invasive procedure, making it safer and easier for young patients to be monitored over time.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital for MRI scans that take pictures of your liver and bile ducts using a large magnetic machine. The researchers will also collect blood samples and may review any recent liver tissue samples you've had. The visit is a one-time visit where you complete these non-invasive tests; no medication or ongoing treatments are part of this study.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
United States